The Ras GTPases function as molecular switches, regulating a multiplicity of biological events. However the contribution, if any, of a speci®c c-Ras isoform (Ha-, N-, or Ki-ras A or B) in the regulation of a given biological or biochemical process, is unknown. Murine C3H10T1/2 ®broblasts transformed with activated (G12V)Ha-ras or (Q61K)N-ras proliferate in serum-free media and have constitutive MAPK activity. The growth factor antagonist, suramin, inhibited the serum-independent proliferation of Ha-ras transformed ®broblasts, but not the serum-independent proliferation of N-ras transformed cells. The inhibition of cell proliferation was concomitant with the abrogation of the constitutive MAPK activity in the Ha-ras transformed ®broblasts. Analysis of the Ras-signalling complexes in immunoprecipitates from Ha-ras transformed cells revealed that Raf-1 co-immunoprecipitated with endogenous c-N-ras but not (G12V)Ha-ras. Pretreatment with suramin resulted in the loss of Raf-1 from c-N-ras immunoprecipitates. A c-N-ras antisense oligonucleotide, which down-regulated c-N-ras protein levels, abrogated the constitutive MAPK activity and serum-independent proliferation of (G12V)Ha-ras transformed cells. The data suggest that Raf-1 has a higher anity for N-ras then Ha-ras in vivo, and c-N-ras function is required for the serum-independent proliferation of Ha-ras transformed cells.
Introduction
The Ras GTPases function as molecular switches, transmitting signals from the plasma membrane to cytosolic serine/threonine kinases. Ras is activated by growth and dierentiation factors and is absolutely required for cell proliferation (Mulcahy et al., 1985; Okuda et al., 1994) . Ras cycles between inactive GDPbound and active GTP-bound forms. In addition to its intrinsic regulatory GTPase activity, Ras activity is controlled by distinct GAP and GEF regulatory proteins (reviewed by Lowy and Willumsen, 1993) . The best characterized of the Ras-dependent signalling pathways, in vivo, is the MAPK cascade. Active Ras⋅GTP binds the cytosolic Raf kinases (Moodie et al., 1993; , recruiting them to the plasma membrane (Stokoe et al., 1994; Marais et al., 1995) where their activities are regulated by incompletely understood mechanisms. However the association of Raf-1 with membrane associated Ras appears to be sucient for Raf-1 activation (Stokoe and McCormick, 1997) . Raf activity mediates the activation of the MAPK cascade through the Raf-dependent activation of MEK1 (Macdonald et al., 1993; Moodie et al., 1993 Moodie et al., , 1994 Van Aelst et al., 1993) , the regulatory kinase for the p42 and p44 MAPKs. MAPK regulates the activity of cytosolic kinases, including PLA 2 (Lin et al., 1993, and RSK2 (Xing et al., 1996) and, upon translocation of active MAPK to the nucleus, the activity of transcription factors including Elk1 (reviewed by Hill and Treisman, 1995) . Ras activity is critical for proliferation since both the microinjection of neutralizing Ras antibodies (Mulcahy et al., 1985) or the ectopic expression of a dominant negative (S17N)Ras protein (Feig and Cooper, 1988; Okuda et al., 1994) block cell proliferation. This inhibition can be circumvented by activated v-raf (Smith et al., 1986) . The MAPK cascade is only one aspect in the complex network of Ras-mediated signal transduction events, but is an essential part of Ras-dependent cell proliferation.
Although several Ras eector molecules have been identi®ed in vitro and from yeast two-hybrid screens, no Ras isoform (Ha-ras, N-ras and Ki-ras A and B) speci®c eector molecules have conclusively been identi®ed. Ras eector molecules include the Raf kinases (Moodie et al., 1993 Jaiswal et al., 1994; Van Aelst et al., 1993; Vojtek et al., 1993) , MEKK (Russell et al., 1995) , RalGDS family members (Hofer et al., 1994; Kikuchi et al., 1994; Spaargaren and Bischo, 1994; Wolthius et al., 1996) , PI 3-OH kinase (PI3K) (Rodriguez-Viciana et al., 1994) , Neuro®bromin (DiBattiste et al., 1993) and AF6 (Kuriyama et al., 1996) . The mechanisms which determine and regulate the formation of speci®c Raseector signalling complexes are not known. The best characterized in vivo Ras-signalling complex is the association between c-Raf-1 and Ras. Using panreactive Ras antibodies, Hallberg et al. (1994) detected a small Raf-1 signal associated with c-Ras immunoprecipitated from EGF-stimulated Rat-1 cells and activated T-lymphoblasts. Raf-1 was also detected in Ras immunoprecipitates from Rat1 cells overexpressing activated (G12E)Ha-ras (Finney et al., 1993) . However, since Raf-1 associates with Ha-, N-and Ki-ras in a GTP-dependent manner in vitro (Moodie et al., 1993; Hamilton and Wolfman, unpublished data) , these studies failed to determine whether, in vivo, Raf-1 was speci®cally associated with a distinct Ras isoform(s).
Since no Ras isoform speci®c eectors have been identi®ed, there is no data to conclusively distinguish whether the four isoforms are functionally redundant or if they regulate distinct biological processes. The four Ras proteins share extensive sequence homology and are identical in their eector-binding domains. In vitro, each Ras isoform associates with the same downstream eectors (Raf-1 and B-raf, PI3K and NF1) in a GTP-dependent manner (Hamilton and Wolfman, unpublished observations) , suggesting the possibility of functional redundancy within the Rasdependent signalling cascades. Indirect evidence, however, supports speci®c biological roles for the Ras isoforms. The non-homologous C-terminal hypervariable regions (spanning amino acids 160 ± 185) are unique for each Ras isoform and are conserved among species (Lowy and Willumsen, 1993) , suggesting they might be functionally important. Changes in gene expression are in¯uenced by the activity of distinct Ras isoforms. The induction of c-fos by TPA is inhibited by the expression of activated Ha-ras but not N-ras or Ki-ras (Carbone et al., 1991) . The eciency of Ras mediated cell transformation in vitro exhibits a degree of cell type dependency. Ha-ras is most potent in transforming rodent ®broblasts whereas cells of myeloid origin are more readily transformed by N-ras (Maher et al., 1995) . This observation re¯ects previous studies demonstrating that mutations in speci®c Ras genes are closely associated with speci®c classes of tumours. N-ras and Ki-ras have a high incidence of mutation in haematological malignancies and in tumours of the gastrointestinal trace respectively (Rodenhuis, 1992) . This accumulated data suggest that speci®c Ras isoforms may be of critical importance in cell lines of distinct origin.
To test the hypothesis that the dierent Ras isoforms are not functionally redundant, we examined the Ras signalling complexes formed in C3H10T1/2 ®broblasts transformed by the minimal expression of an activated (G12V)Ha-ras or (Q61K)N-ras. Each oncogenic Ras was assayed for its contribution to speci®c aspects of cell transformation: constitutive MAPK activity and the ability to proliferate in the absence of exogenous serum or growth factors.
Results

Expression of activated Ras in C3H10T1/2 ®broblasts
Western blot analysis of membrane enriched fractions from normal mouse C3H10T1/2 ®broblasts indicates that they do not express detectable levels of c-Ha-ras protein (Figure 1 ). This observation is not unique to C3H10T1/2 ®broblasts since Downward et al. (1990) observed that T-lymphocytes contained little, if any, c-Ha-ras protein. C3H10T1/2 cells are readily transformed by the ectopic expression of either activated (G12V)Ha-ras (V12H10 cells) or (Q61K)Nras (K61N10 cells), as characterized by the acquisition of a refractile cell morphology and the ability to form foci in soft agar (data not shown). C3H10T1/2 cells which express ectopic wild-type N-ras (G12N10 cells) were not transformed. These cells retained ā attened cell morphology, did not proliferate in the absence of serum and did not form foci (data not shown). The minimal expression of either activated H-ras or N-ras protein resulted in no greater than a onefold increase in the total expression of Ras proteins (Figures 1 and 6e ). This minimal level of ectopic expression was, however, sucient to induce the morphological and proliferative characteristics of cell transformation.
Suramin inhibits the serum-independent proliferation of Ha-ras but not N-ras transformed ®broblasts Ras-induced cellular transformation, in many instances, is associated with a diminished requirement for exogenous growth factors or serum (Pironin et al., 1992) . This Ras-dependent serum-independent proliferation can possibly be attributed to the production of autocrine growth factors, including HB-EGF (McCarthy et al., 1995) , TGFa (Berkowitz et al., 1996) , VEGF (Rak et al., 1995) , IL-1a and IL-6 (Castelli et al., 1994) , and IGF-1 (Dawson et al., 1995) . Ras-transformed V12H10 and K61N10 cells were therefore assayed for their ability to proliferate in the absence of serum for 48 h. The expression of either activated Ha-ras or N-ras resulted in serum-independent growth, with cells proliferating at a rate slightly lower than that observed in the presence of 10% FCS (data not shown). In order to assess the impact of a potential autocrine growth factor mechanism mediating Ras-dependent, serum-independent proliferation, cells were incubated in serum-free DMEM in the presence of increasing concentrations of the growth factor antagonist, suramin (Betsholtz et al., 1986; Kehinde et al., 1995) . Suramin blocks the interaction between growth factors and their cognate receptors and its eects are readily reversible. 50 mM suramin completely inhibited the serum-independent proliferation of Haras transformed V12H10 (Figure 2a (i) ) cells and an unrelated Ha-ras transformed cell line, RasNIH3T3 cells (Figure 2a (iii) ). N-ras transformed K61N10 cells (Figure 2a (ii)) were refractory to suramin. In addition, human HT1080 ®brosarcoma cells, which contain an allelic (Q61K)N-ras mutation, were also refractory to the growth inhibitory property of suramin (Figure 2a  (iv) ). The anti-proliferative eect of suramin was overcome by the direct addition of serum to suramin- Figure 1 Ras isoform expression in C3H10T1/2 ®broblast cell lines. Membrane enriched fractions prepared from parental C3H10T1/2 ®broblasts (10T1/2), and C3H10T1/2 cells expressing (G12V)Ha-ras (V12H10 cells), (Q61K)N-ras (K61N10 cells), and wild-type N-ras (G12N10 cells) were resolved by SDS ± PAGE and immunoblotted with monoclonal antisera speci®c for Ha-ras, N-ras and Ki-ras. Ras proteins were visualized by ECL. 200 mg of membrane fraction was blotted for N-ras and Ki-ras and 300 mg for Ha-ras. Recombinant Ha-ras, N-ras and Ki-ras protein standards (100 ng) are shown on the left. Quantitation of the amount of Ha-ras and N-ras in V12H10 cell membranes using the image analysis programme, NIH Image, indicated that 200 mg of membrane contained approximately 44 ng of c-N-ras, and 300 mg of membrane, 63 ng of Ha-ras (equivalent to 42 ng of Ha-ras in 200 mg of membrane) treated V12H10 cells (Figure 2b ). Therefore the failure of V12H10 cells to proliferate in the presence of suramin was not a consequence of cell toxicity. Thus, activated Ha-ras and activated N-ras appear to promote the serum-independent growth of mouse ®broblasts by distinct mechanisms.
Ras transformed ®broblasts have constitutive MAPK activity
The expression of activated Ras is closely associated with constitutive MAPK activity (Shibuya et al., 1992; Crews and Erikson, 1993; Dent et al., 1993) . MAPK was immunoprecipitated from serum-deprived parental C3H10T1/2 cells, and from control and suramin-treated V12H10 and K61N10 cells using an antibody that recognizes both p42 and p44 MAPKs (TR10). MAPK activity was measured in a direct kinase assay with myelin basic protein (MBP) as a substrate (Moodie et al., 1993) . The MAPK activity of serum-deprived C3H10T1/2 ®broblasts was negligible after 48 h in serum-free DMEM. V12H10 and K61N10 cells both had constitutive MAPK activity. Suramin treatment resulted in almost the complete abrogation of MAPK activity in the V12H10 ®broblasts but not the K61N10 ®broblasts ( Figure 3a) . The suramin-mediated inhibition of MAPK activity was serum-reversible. Serum activated MAPK in suramin-treated V12H10 cells to levels comparable with serum-stimulated C3H10T1/2 and control V12H10 cells, indicating that suramin, itself, did not directly inhibit MAPK activity in V12H10 cells. The inhibition of MAPK activity re¯ected the absence of phosphorylated, active MAPK proteins in suramin treated V12H10 cells. Western blot analysis of cell lysates indicated that suramin treatment resulted in almost the complete loss of phosphorylated MAPK proteins in V12H10 cells, with the level detected being comparable with that detected in quiescent C3H10T1/2 cells. In contrast, suramin had only a minimal eect on the amount of phosphorylated MAPK observed in K61N10 cells (Figure 3b ). The association of Raf-1 with the plasma membrane in vivo, is essential for Raf-1 activation (Stokoe et al., 1994; Marais et al., 1995; Stokoe and McCormick, 1997) a) Suramin inhibits the serum-independent proliferation of Ha-ras transformed ®broblasts. Cells were incubated in serum-free medium containing 0 ± 200 mM suramin for 48 h at 378C. After 48 h the cells were trypsinized and counted using a haemocytometer. The number of cells seeded on day 0 is denoted by (s). All points were performed in duplicate and the data is representative of at least two independent experiments. Results are expressed as the mean+s.e.. (b) The growth inhibitory eect of suramin is reversible. V12H10 ®broblasts incubated in serumfree media for 48 h in the presence of 200 mM suramin were switched to DMEM+FBS and incubated for an additional 24 or 48 h. Cells were then trypsinized and counted using a haemocytometer. Results are expressed as the mean+s.e. MAPK was immunoprecipitated from control, suramin-treated and serum-stimulated V12H10, C3H10T1/2 (10T1/2) and K61N10 cell lysates using a rabbit polyclonal antisera (TR10). The activity of the immunoprecipitated MAPK was measured in a direct kinase assay with MBP as a substrate. Phosphorylated proteins were resolved by SDS ± PAGE. Phosphorylated MBP was visualized and quantitated on a Molecular Dynamics Phosphorimager. The data is representative of at least two separate experiments: (NI) non-immune serum. (b) Abrogation of phosphorylated MAPK protein by suramin. Cell lysates were prepared from serum-starved (48 h) V12H10, C3H10T1/2 and K61N10 cells+suramin. In parallel cultures, cells were serumstimulated for 10 min by the addition of FBS to 10% (v/v) immediately prior to harvesting and lysis. 100 mg of cell lysates were resolved by SDS ± PAGE and immunoblotted for phosphorylated p42 and p44 MAPK. Phosphorylated MAPK was visualized by ECL. A phosphorylated p42 MAPK standard was included as a positive control. The data are representative of three separate determinations. (c) Loss of membrane associated Raf-1 in suramin treated V12H10 cells. Membrane enriched fractions were prepared from control and suramin-treated V12H10 and K61N10 cells, and equal amounts of membrane proteins resolved on 8% SDS ± PAGE gels and immunoblotted for Raf-1. Raf-1 was visualized by ECL 3c). The continued presence of Raf-1 in the membranes of suramin-treated V12H10 cells might possibly be the result of non-Ras mechanisms of membrane localization, such as the association of Raf-1 with caveolae (Mineo et al., 1996) or with cytoskeletal elements (Stokoe et al., 1994) . These observations suggest that in V12H10 cells, the suramin mediated inhibition of the MAPK cascade and cell proliferation may be related to the loss of membrane associated Raf-1. Since this was not observed with K61N10 cells, we conclude that the mechanisms by which activated Ha-ras and N-ras modulate MAPK activity dier from one another.
Activity of Ras-isoform-speci®c polyclonal antisera
Commercially available Ras isoform-speci®c monoclonal antibodies are isoform speci®c by Western immunoblot analysis but fail to immunoprecipitate 32 PaGTP-labelled recombinant Ras proteins (data not shown). Therefore, rabbits were immunized with peptides corresponding to the C-terminal hypervariable regions of each of the Ras proteins and production bleeds tested for their ability to immunoprecipitate recombinant Ras proteins. Recombinant Ha-ras, N-ras and Ki-ras A and B proteins were immunoprecipitated with each of the Ras isoform seras (RIS) and the immunoprecipitates resolved on 15% SDS ± PAGE gels, transferred to PVDF membrane and immunoblotted for Ras using Ras isoform-speci®c monoclonal antibodies. Each RIS speci®cally immunoprecipitated the Ras protein with the corresponding Cterminal region without detectable cross-reactivity with the other Ras proteins (data not shown). Each RIS was then evaluated for its ability to immunoprecipitate mammalian, post-translationally modi®ed c-Ras. c-Ras was immunoprecipitated from a membrane-enriched, detergent-solubilized rat brain particulate fraction, a tissue that contains Ha, N-and both Ki-ras proteins (data not shown). After immunoprecipitation, the immunocomplexes were incubated with [ Koide et al. (1993) had demonstrated that c-Raf-1 could be co-immunoprecipitated with recombinant Ha-ras⋅GTPgS added to cell lysates using the non-neutralizing Y13-238 pan-Ras antibody. To evaluate the ability of each RIS to immunoprecipitate Ras signalling complexes, the membrane-enriched rat brain particulate fraction was incubated in the presence of EDTA and the nonhydrolyzable GTP analogue, GMP-PNP. This`GTPloaded' particulate fraction was mixed with rat brain cytosol and Ras immunoprecipitated with RIS. Immunoprecipitates were resolved by SDS ± PAGE and immunoblotted for Raf-1. Western blot analysis indicated that Raf-1 co-immunoprecipitated with each RIS as a doublet (Figure 4b ), possibly re¯ecting dierences in the post-translational modi®cation of rat brain Raf-1, such as phosphorylation. We conclude, therefore, that each RIS is able to immunoprecipitate the targetted Ras isoform complexed with eector proteins.
Suramin does not inhibit the activation of (G12V) Ha-ras
The anti-proliferative eect of suramin on Ha-ras transformed cells may be a function of a non-speci®c down-regulation of either (G12V)Ha-ras⋅GTP levels or the amount of Ras protein within V12H10 cells. To address this possibility, V12H10 cells were metabolically labelled with 32 P-orthophosphate and Ha-ras immunoprecipitated using the Ha-ras speci®c polyclonal antisera. Labelled guanine nucleotides were eluted from the Ha-ras immunoprecipitates and separated by thin layer chromatography. Quantitation of the eluted radiolabelled GTP and GDP ( Figure 5a ) indicated that suramin had a minimal eect upon the amount of (G12V)Ha-ras⋅GTP immunoprecipitated from V12H10 cells (38.7% versus 39.8% Ras⋅GTP). However immunoprecipitations with the pan-reactive Ras antibody, Y13-259, indicated a modest reduction in Ras⋅GTP levels in the presence of suramin (69.9% versus 50.1% Ras⋅GTP). Western blot analysis of membrane enriched fractions prepared from V12H10 cells indicated that Ha-ras, N-ras and Ki-ras protein levels were unaected by suramin pretreatment ( Figure  5b ). Though suramin may mediate its anti-proliferative eect by reducing the amount of Ras⋅GTP (presumably N-ras and/or Ki-ras) within V12H10 cells, its Immunoprecipitation of c-Ras : Raf-1 complexes from rat brain. A membrane enriched fraction prepared from whole rat brain was incubated with the non-hydrolyzable GTP analogue, GMP-PNP. This`GTP-loaded' fraction was mixed with a Raf-1 containing rat brain cytosol preparation and`c-Ras⋅GTP' immunoprecipitated using the Ras isoform antisera. Immunoprecipitates were resolved on 8% SDS ± PAGE gels and immunoblotted for Raf-1. (Pl) pre-immune rabbit antisera; (KB) Ki-ras B antisera; (KA) Ki-ras A antisera; (N) N-ras antisera; (Ha) Ha-ras antisera. The position of Raf-1 is indicated on the right inhibitory eect on V12H10 cell proliferation is not due to the down-regulation of (G12V)Ha-ras⋅GTP or Ras protein levels.
Raf-1 co-immunoprecipitates with N-ras but not Ha-ras
To further investigate the dierences between Ha-ras and N-ras modulation of serum-independent MAPK activity, both Ha-ras and N-ras were immunoprecipitated from V12H10 and K61N10 cells using the Ha-ras and N-ras speci®c antisera. We observed, as expected, that c-Raf-1 co-immunoprecipitated with N-ras in K61N10 cells (Figure 6c ) but were unable to distinguish between endogenous c-N-ras and the ectopic N-ras in these immunoprecipitates. Surprisingly though, c-Raf-1 co-immunoprecipitated with c-Nras in V12H10 cells (Figure 6a ) and in RasNIH3T3 cells (Figure 6b ). Suramin pretreatment resulted in the complete loss of Raf-1 from N-ras-immunoprecipitates from both V12H10 cells and from RasNIH3T3 cells. Identical results were observed in two other (G12V)Haras transformed C3H10T1/2 cell lines (data not shown). Suramin, however, did not signi®cantly eect the amount of Raf-1 associated with N-ras in the K61N10 cells (Figure 6c ). Suramin also failed to downregulate the association of Raf-1 with N-ras in both a second (Q61K)N-ras C3H10T1/2 cell line and in human HT1080 cells (data not shown). In contrast to previous reports (Finney et al., 1993; Hallberg et al., 1994; Koide et al., 1993) , a signi®cant amount of Raf-1 was not detected in Y13-238 immunoprecipitates, being no better at co-immunoprecipitating Raf-1 than the control non-immune serum. Ras, though, was detected in Y13-238 immunoprecipitates by Western blot analysis (data not shown). Using the Ha-ras and Nras speci®c monoclonal antibodies, which have similar anities for their respective isoforms (data not shown), near-equivalent amounts of Ha-ras and N-ras were detected in Ras immunoprecipitates from Ha-ras transformed cells (Figure 6d ). Thus the failure to detect Raf-1 in Ha-ras immunoprecipitates was not a consequence of the antiseras immunoprecipitating dierent amounts of Ha-and N-ras. Rather, the data implies that Raf-1 preferentially binds to, or has a higher anity for, N-ras. Moreover, immunoblot analysis indicated that greater than 80% of the total Ha-ras was depleted from membranes after Ha-ras immunoprecipitation (data not shown).
The failure to detect Raf-1 in Ras immunoprecipitates using the pan-reactive Ras Y13-238 antibody is most likely a function of the poor ability of this antibody to immunoprecipitate signi®cant amounts of N-ras (Cox et al., 1995) , and because V12H10 cells express only a modest level of (G12V)Ha-ras. Ha-ras:Raf-1 complexes could be detected if Ha-ras expression levels were greatly increased. Dexamethasone-inducible (G12V)Ha-ras Rat2:64-3 and IPTGinducible (G12V)Ha-ras iRas3T3 ®broblasts synthesize large, supraphysiological quantities of membrane associated (G12V)Ha-ras (Figure 6e ), far in excess of the amount of Ha-ras present in V12H10 cells and in RasNIH3T3 cells. Induction of (G12V)Ha-ras in these cell lines resulted in the detection of Raf-1 in Ha-ras immunoprecipitates (Figure 6f ). Once again, Raf-1 was found associated with c-N-ras in both cell lines. The possibility that other Raf family kinases (B-Raf and ARaf) might associate with Ras in vivo was tested using the pan-reactive Raf monoclonal antibody, PBB-1 (Kolch et al., 1990) . Figure 6g indicated that, in V12H10 and K61N10 cells, only one Raf family kinase co-immunoprecipitated with N-ras, and this Raf protein co-migrated with Raf-1. No other Raf kinases were found to co-immunoprecipitate with the Ras proteins under conditions of serum-independent proliferation. We were unable to clearly distinguish whether B-Raf was present in these cells. Two additional immunoreactive bands, though, were detected in cell lysates immunoblotted with the PBB1 antibody which did not co-migrate with either Raf-1 and A-Raf. Furthermore, neither band was detected in Consequently, the suramin-insensitive, constitutive MAPK activity observed in N-ras transformed K61N10 ®broblasts may likely be mediated through the stable association of Raf-1 with N-ras.
c-N-ras antisense oligonucleotides block V12H10 ®broblast proliferation and inhibit MAPK activity
To further clarify the role of c-N-ras in (G12V)Ha-rasmediated serum-independent proliferation and constitutive MAPK activity, N-ras antisense oligonucleotides were used to speci®cally downregulate c-N-ras protein levels in V12H10 cells (Figure 7a ). One antisense oligonucleotide reduced the amount of N-ras by approximately 50% (52.45+5.46% of control c-N-ras protein levels) which was re¯ected in a signi®cant reduction in V12H10 cell proliferation (Figure 7b ). V12H10 cell proliferation was inhibited using 3 mM and 10 mM antisense oligonucleotides, with cell numbers reduced by 40% (P50.05) relative to untreated control cells and cells incubated with 10 mM N-ras sense oligonucleotides. More importantly, the N-ras antisense oligonucleotide almost completely abrogated the constitutive MAPK activity (Figure 7c ) and the presence of phosphorylated p42 and p44 MAPKs (Figure 7d ). The sense oligonucleotide had a very slight inhibitory eect on N-ras protein levels (89.50+10.50% of control c-N-ras protein levels) and cell proliferation, but no eect either upon basal MAPK activity or the presence of phosphorylated p42 and p44 MAPK in V12H10 cells. The 50% reduction in c-N-ras protein levels within V12H10 cells was, however, sucient to inhibit both the constitutive MAPK activity and cell proliferation. This supports our observations that minimally expressed (G12V)Ha-ras does not directly mediate MAPK activity in murine C3H10T1/2 ®broblasts. Rather, MAPK activity appears to be linked to c-Nras function, since down-regulation of N-ras protein levels has a signi®cant eect upon both MAPK activity and serum-independent proliferation. These data correlate with our observations that the suraminmediated disruption of the N-ras:Raf-1 complex in Ha-ras transformed cells results in the near-complete abrogation of MAPK activity and inhibition of serum- independent proliferation. Therefore, MAPK activity in (G12V)Ha-ras transformed mouse V12H10 fibroblasts is not a consequence of a complex between Raf-1 and the activated (G12V)Ha-ras, but rather through its association with c-N-ras. Subsequently, the downregulation of c-N-ras protein levels or the disruption of the c-N-ras:Raf1 complex results in the inhibition of MAPK activity and cell proliferation. The data, therefore, implicates N-ras but not Ha-ras as the regulatory Ras isoform of the MAPK cascade in Haras transformed C3H10T1/2 ®broblasts.
Discussion
MAPK activation is an absolute requirement for ®broblast proliferation (Pages et al., 1993) and is concommitant with the expression of activated Ras in vivo. Raf-1 activation is sucient to stimulate cell proliferation and MAPK activation Shibuya et al., 1992; Kortenjann et al., 1994) , and both these Ras-dependent biological processes can be blocked by dominant negative Raf-1 constructs (Schaap et al., 1993) . One function of Ras⋅GTP may be to recruit Raf-1 to the plasma membrane for subsequent activation. This recruitment function of Ras can be circumvented by directly targetting Raf-1 to the plasma membrane by fusion with a Ki-rasB CAAX sequence (Stokoe et al., 1994) . Although Rasinduced cell transformation has previously been demonstrated to require synergy between at least two distinct Ras activities (White et al., 1995; Joneson et al., 1996) , the interaction between Ras and Raf-1 in vivo is critical in the activation of the MAPK cascade and for cell proliferation. In vitro, active Ras associates with the upstream eectors of the MAPK pathway, Raf-1 and MEK1 (Macdonald et al., 1993; Moodie et al., 1993 Vojtek et al., 1993) and directs the Raf/ MEK/MAPK kinase cascade. Our data, however, suggest that activated (G12V)Ha-ras does not directly mediate the MAPK kinase cascade in mouse fibroblasts. Activated (G12V)Ha-ras does not appear to bind Raf-1. Rather, Raf-1 co-immunoprecipitates with c-N-ras in Ha-ras transformed cells and is lost from c-N-ras immunoprecipitates after treatment with suramin. Since suramin completely abrogates MAPK activity and cell proliferation, the data suggest that the association of Raf-1 with c-N-ras mediates the constitutive MAPK activity in Ha-ras transformed V12H10 cells. Stokoe and McCormick (1997) recently reported that the interaction between Ras and Raf-1, alone, was sucient for Raf-1 activation. Moreover, the down-regulation of c-N-ras protein levels inhibits cell proliferation and abrogates MAPK activity. The functional relationship between N-ras and Raf-1 is further supported by our observations that suramin has a minimal eect upon the stability of the N-Ras:Raf-1 complex, MAPK activity, and the serum-independent proliferation of N-ras transformed K61N10 mouse ®broblasts.
Since suramin is a growth factor antagonist, the mechanism of (G12V)Ha-ras dependent activation of MAPK might involve an autocrine mechanism of action. Indeed, media conditioned by V12H10 cells possesses an activity that stimulates MAPK activity in quiescent C3H10T1/2 ®broblasts (data not shown). Oldham et al. (1996) reported that media conditioned by Ha-ras transformed epithelial cells induces the morphological transformation of normal epithelial cells. This morphological transformation could be mimicked by exogenous TGFa but not be media conditioned by Raf transformed epithelial cells. Suramin inhibits the binding of polypeptide growth factors to their cognate receptors (Kehinde et al., 1995) . It can, therefore, be postulated that the anti-proliferative eect of suramin may be mediated through the blocking of a growth factor receptor-mediated association of Raf-1 with N-ras. Therefore, if N-ras directs Raf-1 signalling, N-ras transformed cells would be, and are, insensitive to the anti-proliferative eect of suramin. In addition, our data suggest that in a mouse background, c-N-ras possesses a higher anity for Raf-1 than does activated (G12V)Ha-ras. The action of (G12V)Ha-ras might, therefore, be to facilitate the synthesis and/or secretion of an unidenti®ed autocrine growth factor(s). In this instance, (G12V)Ha-ras and c-N-ras functions might synergize to produce cell transformation. Alternatively, other Ras eectors may be directly regulated by (G12V)Ha-ras.
Little is known about the stability and duration of cRas-eector complexes. Our data suggest that the c-N-ras:Raf-1 complex is a stable entity at 48C since Raf-1 is detected in N-ras immunoprecipitates after a 4 h immunoprecipitation (Figure 6a ± c) . The formation of a Ras:Eector complex is a mutually exclusive process, preventing the interaction of Ras with other eectors, including regulatory GAP proteins (RasGAP and NF-1) (Moodie et al., 1995) . When Ras is bound to an eector, GAP proteins are unable to promote the hydrolysis of Ras-bound GTP. Consequently, the inactivation and dissociation of the active Ras:Eector complex is not regulated by GAP activity. Hermann et al. (1995) demonstrated that the dissociation of the Ras-binding domain (RBD) of Raf-1 from c-Ha-ras was dependent upon the intrinsic GTPase activity of c-Ha-ras (approximately 30 min at 378C). Thus, the association of Ras with an eector other than a GAP protein results in a stable signalling complex, with each eector functioning as a potential GDI protein. The intrinsic GTPase activity is unaltered by the association of c-Ras⋅GTP with Raf-RBD (Herrmann et al., 1995) . Consequently, the duration of a c-Ras-Raf complex may depend solely on the cRas⋅GTP-Raf-1 GTPase rate. Furthermore, it is most likely that the activation of Raf-1 occurs when Raf-1 is complexed with Ras (Stokoe and McCormick, 1997) .
Although activated (Q61K)N-ras alone appears sucient to activate the MAPK cascade, most probably functioning through its binding to Raf-1, the data suggests that there is a level of co-operation between the activated Ha-ras and c-N-ras proteins to produce a fully transformed phenotype in mouse ®broblasts. The role of Ki-ras in serum-independent cell proliferation was not addressed in these experiments and therefore cannot be excluded. Raf-1, though, is unlikely to be an immediate downstream eector for Ki-ras in V12H10 ®broblasts since Ki-ras was readily detected in pan-Ras Y13-238 immunoprecipitates (data not shown) but Raf-1 was not (Figure  6a ± c) .
Most studies of Ras signalling and Ras-signalling complexes have utilized expression systems which grossly overproduce activated Ras (Finney et al., 1993) , or have entailed the addition of microgramme quantities of recombinant Ras protein to cell lysates (Koide et al., 1993) . These methods, though informative, more than likely overwhelm the normal cellular machinery that not only regulates Ras activity, but also potential mechanisms that determine and facilitate speci®c Ras isoform-eector interactions. In vivo, this would result in aberrant, promiscuous cellular signalling and cell transformation via non-physiological or low-anity Ras-signalling complexes. Therefore, what is observed may be misleading. The use of supraphysiological levels of ectopioc Ras, and pan-reactive Ras antibodies do not fully address the possibility that the Ras isoforms regulate distinct signalling cascades and biological events. We do not detect Ha-ras protein in any of the ®broblast cell lines available in the laboratory (data not shown), suggesting that there may be qualitative functional dierences between Ha-ras and N-ras or Ki-ras signalling events. Indeed, the eciency of the dierent Ras proteins to mediate cell transformation exhibits a degree of cell-type dependency. Rat2 ®broblasts can be transformed by the induction of minimal amounts of (G12V)Ha-ras protein (Maher et al., 1995;  Yoder-Hill, Kirshmeier and Wolfman, submitted) but not by (Q61K)N-ras or (G12D)N-ras (Yoder-Hill, Kirshmeier and Wolfman, submitted). This supports the observations in this report that at minimal levels of Ras expression there are signi®cant dierences in Ras isoform-dependent signalling systems.
The minimal expression of activated Ras proteins is sucient to induce cell transformation and constitutive MAPK activity. Activated Ha-ras, however, appears to indirectly activate the MAPK cascade. There appears to be co-operation between (G12V)Ha-ras and c-N-ras such that c-N-ras may function downstream of activated Ha-ras. The signi®cant inhibition of MAPK activity and serum-independent cell proliferation through the modest reduction in N-ras protein levels is somewhat surprising. However, since minimal increases in activated Ras induce cell transformation, conversely it is possible that modest decreases in Ras levels could be growth inhibitory. Ecient Ras signalling may be dependent upon a threshold level of Ras⋅GTP being attained. Biological processes are tightly regulated and many require the attainment of speci®c thresholds of activity before a response is initiated (e.g. the action potential in neurons). It is possible that the modest (50%) reduction in N-ras protein levels in N-ras antisense oligonucleotide treated V12H10 cells results in the inhibition of MAPK activity by preventing achievement of a speci®c threshold level of active N-ras. The minimal amount of activated Ras required to induce MAPK activation has never been determined since most studies have employed overexpression of an ectopic protein to determine its role in a given biological or biochemical event. However, it is possible that only a small amount of Ras need be activated to produce a Ras-dependent signalling cascade, since the signals that go through Ras undergo ampli®cation e.g. the MAPK cascade. Consequently, it is perfectly feasible that a certain, de®nable amount of Ras⋅GTP or activated Ras must be present before a Ras-dependent signalling event can proceed.
The apparent distinction between the abilities of Haras and N-ras to directly control the MAPK cascade in vivo contrasts the lack of distinguishable phenotype reported for N-ras knockout mice (Umano et al., 1995) . The possibility exists that during early development there is a degree of Ras plasticity such that other Ras isoforms are able to compensate for a null Ras defect. These novel observations suggest that although there may be a degree of functional redundancy among the Ras proteins, Ha-ras and N-ras appear to control distinct biological and biochemical activities, and that c-N-ras co-operates with (G12V)Ha-ras to produce a fully transformed phenotype.
Materials and methods
Reagents
All reagents were Molecular Biology grade. Cell culture and transfections V12H10 ®broblasts (originally named 11A) expressing activated (G12V)Ha-ras are derived from normal mouse C3H10T1/2 ®broblasts by transfection and were a kind gift from EJ Taparowsky (Purdue University, Lafayette, IN). RasNIH3T3 expressing activated (G12V)Ha-ras are derived from mouse NIH3T3 ®broblasts. Human HT1080 ®brosarcoma cells were provided by DW Leaman and GR Stark, (Dept. of Molecular Biology, Cleveland Clinic Foundation). K61N10 and G12N10 ®broblasts, expressing activated (Q61K)N-ras and wild-type (G12)N-ras respectively, are derived from C3H10T1/2 ®broblasts by transfection with N-ras expression vectors pIBW3 NT (Q61K) and pIBW3 NN (G12) using the lipofectamine method (GIBCO/BRL) for 6 h at 378C. Rat2 ®broblasts were transfected with (G12V)Ha-ras cloned into the dexamethasone inducible pMAM vector. Transfected cells were selected in DMEM+FCS containing 750 mg/ ml G418. Clonal transfected cell lines were isolated from discrete foci and propagated in DMEM+FCS. iRas3T3 cells (McCarthy et al., 1995) 
Ras induction
(G12V)Ha-ras was induced in iRas3T3 cells and Rat2:64-3 cells with 5 mM IPTG or 100 mM dexamethasone, respectively, for 48 h in serum-free DMEM.
Serum-independent cell proliferation assays
Ras transformed ®broblasts were seeded at 1.5 ± 5.0610 5 cells in 100 mm culture dishes and allowed to attach for 6 h at 378C. Attached cells were washed twice with serum-free DMEM and incubated in the presence of 0 ± 200 mM suramin (Research Biochemicals International, Natick, MA). After 48 h the cells were trypsinized and counted using a haemocytometer. To determine whether the anti-proliferative eect of suramin was reversible, V12H10 cells were incubated in serum-free media for 48 h in the presence of 200 mM suramin. After 48 h the cell monolayer was washed twice and media containing 10% FCS added. The cells were incubated for an additional 24 or 48 h, then trypsinized and counted using a haemocytometer. The eect of N-ras sense and antisense oligonucleotides on the serum-independent proliferation of V12H10 cells was measured by seeding 1.0 ± 2.0610 5 cells in 100 mm culture dishes and allowing them to attach for 6 h at 378C. Attached cells were washed twice with serum-free DMEM and incubated for 96 h in the presence of 0 ± 10 mM sense or antisense oligonucleotides, with the medium replaced with fresh oligonucleotide-containing DMEM after 48 h. At 96 h the cells were trypsinized and counted using a haemocytometer. Cell proliferation in the presence of the oligonucleotides was expressed as the percentage of control (no oligonucleotide) cultures.
Preparation of membrane-enriched fractions
Cell monolayers were washed twice with ice-cold Tris Buered Saline (TBS: 150 mM NaCl, 50 mM Tris pH 7.4), scraped and pelleted by centrifugation at 800 r.p.m. for 5 min at 48C. A cytosol fraction was prepared by resuspending the cell pellet in 1.0 ml of MOPS buer (20 mM MOPS pH 7.4, 5 mM MgCl 2 , 2 mM EDTA, 10% (v/v) glycerol, plus protease and phosphatase inhibitors) containing 0.05% (w/v) saponin and incubating on ice for 30 min. Cell ghosts were collected by centrifugation at 13 000 r.p.m. for 10 min at 48C in a refrigerated bench microcentrifuge. The pellet was washed three times with ice-cold TBS and an enriched membrane fraction prepared by extracting the cell pellet for 20 min on ice with 200 ± 500 ml of 1.0% (w/v) CHAPS in MOPS buer (CHAPS lysis buer). All of the Ras proteins are solubilized by the addition of 1.0% CHAPS (Wolfman, unpublished observation). Insoluble cellular debris was pelleted by centrifugation at 13 000 r.p.m. at 48C. The protein concentration of the membrane enriched fractions was determined by Bradford assay.
Antibody production
Polyclonal antiseras were raised to peptides corresponding to Ha-ras amino acids 166 ± 180, Ki-rasA and Ki-rasB amino acids 173 ± 183, and N-ras amino acids 166 ± 179. Peptides were synthesized and coupled to bovine serum albumin (BSA), using the bifunctional reagent m-Maleimidobenzoyl-N-hydroxysuccinimide ester (Sigma, St Louis, MO). BSA-Ras peptide conjugates were puri®ed from unconjugated peptides by gel ®ltration on a 14.060.5 cm Sephadex G25 column and dialyzed against TBS. Rabbits were immunized according to standard protocols (Biodesign International, Kennebunk, ME). Production bleeds were assayed for their ability to immunoprecipitate recombinant Ras proteins and to detect recombinant Ras protein by Western analysis. Each Ras antisera did not cross react with the other Ras proteins as determined by Western blot analysis and immunoprecipitation of 32 PaGTP-labelled Ras. The pan-Ras reactive Y13-238 and Y13-259 rat monoclonal antibodies were obtained from hybridoma culture supernatants by concentration through a Centriprep 30 membrane (Amicon, Beverly, MA).
N-ras sense and antisense oligonucleotide sequences
The murine N-ras mRNA sequence was analysed using the RNA folding programme, Mulfold. Several N-ras speci®c sense and antisense phosphorothioate-modi®ed DNA oligonucleotides were synthesized (Eckstein, 1985) . One oligonucleotide corresponding to a 20 base sequence in exon 2 of the c-N-ras gene (GenBank Accession number M12122), proved to be eective in down-regulating c-N-ras protein levels. This was TGATTTGCTATTATTGATGG for the N-ras antisense sequence and CCATCAATAA-TAGCAAATCA for the N-ras sense sequence.
Immunoblot analysis
Mouse monoclonal and rabbit polyclonal antibodies against Raf-1 were purchased from Transduction Laboratories, Louisville, KY. The pan-reactive Raf monoclonal antibody, PBB1, was obtained from Martin McMahon, DNAX Corp, CA. The phosphorylated MAPK (phospho-MAPK)-speci®c rabbit polyclonal antibody was purchased from Promega, Madison, WI. Ha-ras, N-ras and Ki-ras speci®c monoclonal antibodies were purchased from Santa Cruz Biotechnology, Santa Cruz, CA. 200 ± 300 mg of denatured membrane-enriched fractions and 100 mg of denatured 1.0% CHAPS cell lysates were resolved on discontinuous SDS ± PAGE gels for Ras isoform (15%) and phosphoMAPK blots (8%), respectively. Resolved proteins were transferred to Immobilon P (Millipore, Bedford, MA) PVDF membranes and blocked with TBS+0.1%NP40 (TBS+NP40) containing 5% dry milk and 1% FBS for 1 h at room temperature. After washing with TBS+NP40, the membrane was incubated with primary antibody for 1 h at room temperature. Membranes were washed ®ve times with TBS+NP40 (10 min wash) and then incubated for 1 h with anti-mouse or antirabbit horseradish peroxidase (HRP) conjugated secondary antibodies (1 : 3000 working dilution). After washing, the immunoreactive bands were visualized using standard enhanced chemiluminescence (ECL) techniques.
Co-immunoprecipitation of Raf-1 with Ras
Cell monolayers were washed twice with ice-cold TBS, scraped and pelleted by centrifugation at 800 r.p.m. for 5 min at 48C. The cell pellet was lysed in 500 ml of ice-cold 1% CHAPS lysis buer (20 mM MOPS pH 7.4, 1% (w/v) CHAPS, 10% (v/v) glycerol, 150 mM NaCl, 2 mM EDTA, 5 mM MgCl 2 , 0.05% (v/v) NP40, plus protease and phosphatase inhibitors) for 20 min on ice. Lysates were clari®ed by centrifugation at 13 000 r.p.m. for 10 min at 48C in a refrigerated bench microcentrifuge. Clari®ed lysates were pre-absorbed with 200 ml of Protein A Sepharose (PAS) for 10 min on ice and recentrifuged at 13 000 r.p.m. for 5 min at 48C (PAS was prepared as a 1 : 4 slurry in TBS+NP40). The protein concentration of the lysates was determined by Bradford assay. 50 ml of Ras speci®c polyclonal antisera was added to the lysates and permitted to immunoreact for 3 h at 48C with constant rotation. Insoluble material was pelleted by centrifugation at 13 000 r.p.m. for 10 min at 48C, and the reclari®ed lysate transferred to a clean eppendorf containing 200 ml PAS and precipitated for 1 h at 48C. Immunoprecipitates were collected by centrifugation at 48C and washed ®ve times with ice-cold TBS+NP40. Laemlli buer was added and the immunoprecipitates heated for 5 min at 1008C. The immunoprecipitates were resolved on 8% SDS ± PAGE gels and transferred to an Immobilon P membrane for Western blot analysis. Membranes were blotted for Raf-1 with a Raf-1 speci®c monoclonal antibody and detected with a HRP-conjugated anti-mouse secondary antibody. Immunoreactive bands were visualized by ECL.
Immunoprecipitation of c-Ras by Ras-isoform speci®c polyclonal antibodies
Rat brain contains c-Ha-ras, c-N-ras and c-Ki-ras proteins (data not shown). A rat brain particulate fraction was solubilized in 20 mM MOPS pH 7.4 buer containing 1.0% CHAPS, 0.04% deoxycholate, and protease inhibitors (Wolfman and Macara, 1990) . c-Ras isoforms were immunoprecipitated from 3.5 mg of the membraneenriched brain fraction using Ras-isoform speci®c polyclonal antisera or Y13-238 for 3 h at 48C. Insoluble material was pelleted by centrifugation at 13 000 r.p.m. for 10 min at 48C, and the clari®ed lysate incubated with PAS for 1 h at 48C to precipitate Ras. Immunoprecipitates were washed three times with P21+NP40 buer containing 10 mM EDTA and three times with P21 buer containing 10 mM EDTA. Endogenous c-Ras was detected by exchanging Ras bound guanine nucleotides for [ 32 P]aGTP (3000 Ci/mmol) in the presence of EDTA. Immunoprecipitates were incubated with 50 ml of P21 buer containing 10 mM EDTA, 1 mM ATP and 10 mCi [ 32 P]aGTP for 90 min at room temperature. The GTP-exchange reaction was stopped by the addition of MgCl 2 to 20 mM and the immunoprecipitates washed three times with P21 buer containing 20 mM MgCl 2 . Scintillation¯uid was added and the radioactivity associated with the immunoprecipitates measured.
Ha-ras-GTP measurements V12H10 cells grown to 50% con¯uency in complete media were switched to phosphate-free Eagles Modi®ed Essential Media containing 0.1% FBS in the absence or presence of 200 mM suramin for 48 h. [ 32 P]orthophosphate was added to each dish (0.1 mCi/ml) 18 h prior to harvesting. Cells were washed twice with ice-cold TBS and lysed in 500 ml of ice-cold 1% CHAPS lysis buer. Ha-ras was immunoprecipitated from the lysates as described previously. Immunoprecipitates were collected by centrifugation at 48C, washed ®ve times with ice-cold TBS+NP40 and once with ice cold P21 buer (200 mM sucrose, 20 mM MOPS, 4 mM MgCl 2 , 1 mM dithiothreitol, pH 7.4). Radiolabelled nucleotides were released from the Ha-ras immunoprecipitates by heating for 5 min at 1008C in 50 ml of P21 buer containing 5 mM EDTA, chilled on ice and centrifuged. 5 ml of eluted nucleotides was spotted onto a PEI-F Cellulose thin layer chromatography (TLC) plate and developed using a 0.75 M Tris/0.45 M HCl/0.35 M LiCl solvent system. The TLC plate was air-dried and the radioactivity associated with the guanine nucleotide spots that co-migrated with GDP and GTP standards visualized and quantitated using a Molecular Dynamics Phosphorimager. The ratio of Ras bound GTP was expressed as a percentage of total Ras bound guanine nucleotides using the formula (GTP/GDP+GTP)6100%.
Measurement of MAPK activity
Cells were grown for 48 h in serum-free media with or without suramin, or for 96 h in the presence of N-ras sense and antisense oligonucleotides. In serum-stimulation experiments, 48 h serum-starved cells were stimulated for 10 min by the addition of FBS to 10% (v/v) directly to the culture dish. Cell monolayers were washed and the cells scraped and lysed as previously described. MAPKs were immunoprecipitated from 250 mg of cell lysate using a rabbit polyclonal antisera to MAPK (TR10) or a nonimmune rabbit serum precoupled to PAS. MAPK was immunoprecipitated for 2 h at 48C with constant rotation. Immunoprecipitates were washed twice with TBS+NP40, twice with P21+NP40 buer (20 mM MOPS pH 7.4, 200 mM Sucrose, 4 mM MgCl 2 , 1 mM DTT, 0.02% NP40) and a ®nal wash with P21 buer. 50 ml of kinase buer (P21 buer containing 10 mM ATP, 10 mM MgCl 2 , 10 mCi [ 32 P]gATP and 10 mM phosphatase inhibitors; Moodie et al., 1993) containing 25 mM myelin basic protein (MBP; Sigma, St Louis, MO) was added to each immunoprecipitate and incubated at 378C for 20 min. The kinase reaction was stopped by the addition of 50 ml of 26 Laemlli buer and the phosphorylated proteins resolved on a discontinuous 15% SDS ± PAGE gel. Phosphorylated MBP was visualized and quantitated on a Molecular Dynamics Phosphorimager.
